Cargando…
Fournier’s gangrene under SGLT-2 inhibitor therapy: A literature review and case report
INTRODUCTION: Fournier’s gangrene is a rare, life-threatening necrotizing infection of the perineum. In 2018, the U.S. Food and Drug Administration (FDA) issued a warning regarding a possible connection between Fournier’s gangrene and new oral anti-diabetic drugs called SGLT-2 inhibitors. There are...
Autores principales: | Ellegård, Lisa, Prytz, Mattias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711186/ https://www.ncbi.nlm.nih.gov/pubmed/33395875 http://dx.doi.org/10.1016/j.ijscr.2020.11.100 |
Ejemplares similares
-
Fournier’s Gangrene: A Coexistence or Consanguinity of SGLT-2 Inhibitor Therapy
por: Chowdhury, Tutul, et al.
Publicado: (2022) -
Fournier's Gangrene: Report of 2 Cases
por: Hota, Prasan Kumar
Publicado: (2012) -
SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study
por: Wang, Tongtong, et al.
Publicado: (2020) -
Fournier’s Gangrene in the Setting of Underlying Carcinoma: A Case Report and Review of the Literature
por: Mann, Adam J, et al.
Publicado: (2020) -
Fournier's Gangrene in Children: Report on 7 Cases and Review of Literature
por: Rouzrokh, Mohsen, et al.
Publicado: (2014)